# Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck

> **NCT04397341** · PHASE2 · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 58 (actual)

## Conditions studied

- Locally Advanced Head and Neck Carcinoma

## Interventions

- **DRUG:** docetaxel, cisplatin, fluorouracil

## Key facts

- **NCT ID:** NCT04397341
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-01
- **Primary completion:** 2016-08-30
- **Final completion:** 2019-09-15
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397341, "Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04397341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*